Lukas Biomedical Inc. (TPEX:6814)

Lukas Biomedical Statistics

Total Valuation

TPEX:6814 has a market cap or net worth of TWD 1.06 billion. The enterprise value is 1.18 billion.

Market Cap	1.06B
Enterprise Value	1.18B

Important Dates

The next estimated earnings date is Monday, May 11, 2026.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6814 has 41.87 million shares outstanding. The number of shares has increased by 13.00% in one year.

Current Share Class	41.87M
Shares Outstanding	41.87M
Shares Change (YoY)	+13.00%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	7.71%
Owned by Institutions (%)	2.87%
Float	14.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.91
PB Ratio	4.42
P/TBV Ratio	4.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.81
EV / Sales	6.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.98

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.65.

Current Ratio	0.80
Quick Ratio	0.40
Debt / Equity	0.65
Debt / EBITDA	n/a
Debt / FCF	-2.24
Interest Coverage	-25.28

Financial Efficiency

Return on equity (ROE) is -30.26% and return on invested capital (ROIC) is -12.12%.

Return on Equity (ROE)	-30.26%
Return on Assets (ROA)	-11.23%
Return on Invested Capital (ROIC)	-12.12%
Return on Capital Employed (ROCE)	-26.01%
Weighted Average Cost of Capital (WACC)	4.49%
Revenue Per Employee	1.87M
Profits Per Employee	-892,010
Employee Count	96
Asset Turnover	0.40
Inventory Turnover	1.95

Taxes

In the past 12 months, TPEX:6814 has paid 1.87 million in taxes.

Income Tax	1.87M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.63% in the last 52 weeks. The beta is 0.12, so TPEX:6814's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+5.63%
50-Day Moving Average	25.91
200-Day Moving Average	26.97
Relative Strength Index (RSI)	48.39
Average Volume (20 Days)	21,945

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6814 had revenue of TWD 179.49 million and -85.63 million in losses. Loss per share was -2.05.

Revenue	179.49M
Gross Profit	107.87M
Operating Income	-81.16M
Pretax Income	-83.76M
Net Income	-85.63M
EBITDA	-56.12M
EBIT	-81.16M
Loss Per Share	-2.05

Balance Sheet

The company has 34.75 million in cash and 156.02 million in debt, with a net cash position of -121.27 million or -2.90 per share.

Cash & Cash Equivalents	34.75M
Total Debt	156.02M
Net Cash	-121.27M
Net Cash Per Share	-2.90
Equity (Book Value)	240.19M
Book Value Per Share	5.76
Working Capital	-22.49M

Cash Flow

In the last 12 months, operating cash flow was -61.43 million and capital expenditures -8.22 million, giving a free cash flow of -69.64 million.

Operating Cash Flow	-61.43M
Capital Expenditures	-8.22M
Depreciation & Amortization	12.03M
Net Borrowing	-43.83M
Free Cash Flow	-69.64M
FCF Per Share	-1.66

Margins

Gross margin is 60.10%, with operating and profit margins of -45.22% and -47.71%.

Gross Margin	60.10%
Operating Margin	-45.22%
Pretax Margin	-46.67%
Profit Margin	-47.71%
EBITDA Margin	-31.27%
EBIT Margin	-45.22%
FCF Margin	n/a

Dividends & Yields

TPEX:6814 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.00%
Shareholder Yield	-13.00%
Earnings Yield	-8.07%
FCF Yield	-6.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3